Bluebook
Diagnostics and Tools July 2024
2024 - July: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Eurobio Scientific was acquired by MBK Partners
- Astorg announced its acquisition of Hamilton Thorne
- CytoReason closed a $80MM Series A Financing, led by NVDIA Corporation, Thermo Fisher Scientific, Pfizer Inc, OurCrowd Ltd